Information for funded teams
Contractual information and guidance on managing our funding, for Cancer Grand Challenges teams and their host institutions.Key documents
When receiving Cancer Grand Challenges funding, all investigators and institutions participating in a team are required to sign up to a Cancer Grand Challenges Award Agreement, also signed by the research funders: Cancer Research UK and the National Cancer Institute (NCI).
The Award Agreement incorporates the terms outlined in the Award Management and Funding Policy Guide, Commercialisation Policy and National Cancer Institute Other Transaction Award Policy Guide. You can access all of these documents on this page, as well as the Cancer Research UK Allowable Costs Guidance.
Each funded institution will also be subject to specific terms detailed in their Notice of Award and Grant Award Letter. All contractual documents may be updated from time to time, and the most up-to-date versions will be posted here.
The Cancer Grand Challenges Award Agreement is the lead contracting document to be signed by all parties within a team. The Award Agreement linked above is a template; funded researchers should refer to their own populated and executed Agreement. Please contact info@cancergrandchallenges.org if you aren’t able to locate this.
The Award Management and Funding Policy Guide is a guide to the management of Cancer Grand Challenges awards starting in 2022 and beyond.
The Commercialisation Policy outlines the commercialisation process entered into by all parties
The Cancer Research UK Allowable Costs Guidance provides teams with information about items that can be charged to the Cancer Research UK portion of Cancer Grand Challenges funding.
NCI will issue Cancer Grand Challenges awards to Institutions using the NIH Other Transaction (OT) Authority, granted under Section 402(n) of the Public Health Service Act. The NCI Cancer Grand Challenges Other Transaction Award Policy Guide outlines terms specific to this.